Login to Your Account

CAT Reaches Agreement Over Patents With MorphoSys, Crucell

By Nuala Moran

Wednesday, December 25, 2002
LONDON - Peace has broken out in long-running wars over antibody phage display patents, with Cambridge Antibody Technology Group plc granting licenses to MorphoSys AG and Crucell NV, and all existing litigation between the companies being withdrawn.(BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription